Shanghai Pharmaceuticals Holding Stock Today
| SHPMF Stock | USD 1.82 0.68 59.65% |
Performance8 of 100
| Odds Of DistressLess than 9
|
Shanghai Pharmaceuticals is trading at 1.82 as of the 28th of November 2024. This is a 59.65 percent increase since the beginning of the trading day. The stock's lowest day price was 1.82. Shanghai Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Shanghai Pharmaceuticals Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 28th of November 2024. Click here to learn more.
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. The company has 919.07 M outstanding shares. More on Shanghai Pharmaceuticals Holding
Moving together with Shanghai Pink Sheet
Moving against Shanghai Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Shanghai Pink Sheet Highlights
| Vice President | Yongzhong Li |
| Business Concentration | Medical Distribution, Healthcare (View all Sectors) |
Shanghai Pharmaceuticals Holding [SHPMF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Shanghai Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Pharmaceuticals classifies itself under Healthcare sector and is part of Medical Distribution industry. The entity has 919.07 M outstanding shares.
Shanghai Pharmaceuticals Holding has accumulated about 37.3 B in cash with 5.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Shanghai Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationShanghai Pharmaceuticals shows a total of 919.07 Million outstanding shares. Shanghai Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Pharmaceuticals Risk Profiles
| Mean Deviation | 4.14 | |||
| Semi Deviation | 5.64 | |||
| Standard Deviation | 10.63 | |||
| Variance | 113.03 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Shanghai Pharmaceuticals Corporate Management
| Ying Ke | Director Center | Profile | |
| Tao Zhong | Board VP | Profile | |
| Man Cho | Pres Director | Profile | |
| Jinqi Yu | G Mang | Profile | |
| Shunjiang Yu | Chief Officer | Profile | |
| Shui ACS | Joint Sec | Profile |
Other Information on Investing in Shanghai Pink Sheet
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.